California Doctors Again Press For More Money To Treat Poor Patients
They want the state’s new tobacco tax to help pay for a raise in Medicaid rates, but so far Gov. Jerry Brown has other plans for that money.
Health Industry
2,621-2,640 of 4,003 results
-
-
Senators Demand Answers About Possible Probe Of HHS Secretary Price
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him.
By Rachel Bluth and Emily Kopp -
March Madness Vasectomies Encourage Guys To Take One For The Team
Some urologists use March Madness as an opportunity to market vasectomy services, offering men the excuse to sit on the sofa for three days to watch college basketball while they recover.
-
Justice Department Joins Lawsuit Alleging Massive Medicare Fraud By UnitedHealth
The Department of Justice is joining a whistleblower lawsuit in a fraud case against UnitedHealth in which damages could top $1 billion.
By Fred Schulte -
Repeal & Replace Watch
Insurers May Notch Bigger Profits From Fewer Customers In ‘Trumpcare’
As Congress and the White House try to strike a bargain on an Obamacare repeal plan, the insurance industry likes what it’s seeing.
-
Repeal & Replace Watch
Popular Guarantee For Young Adults’ Coverage May Be Health Law’s Achilles’ Heel
Republicans and Democrats don’t agree on much these days, but both parties want to keep the health law’s provision to allow adults to stay on their parents’ plan until age 26. But that could be hurting the marketplace’s insurance pools.
-
GAO To Launch Investigation Of FDA’s Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
-
Repeal & Replace Watch
House Republicans Recycle Controversial 2003 Bill To Boost Small-Business Insurance
The legislation, passed by the House, would allow nationwide “association health plans.” But consumer advocates have raised serious concerns about such options in the past.
-
Repeal & Replace Watch
In Deep-Red Western N.C., Revered Congressman Leads Charge Against GOP Bill
Is Republican Rep. Mark Meadows the man who would kill "Trumpcare"? He enjoys strong support in his gerrymandered western North Carolina district as he leads conservative opposition to the GOP’s plan for repealing and replacing Obamacare.
-
Repeal & Replace Watch
GOP Bill’s Unheralded Changes In Rules Could Undermine Health Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
By Emily Bazar -
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
By Bruce Horovitz and Julie Appleby -
Travel Ban Adds Stress To ‘Match Week’ For Some Doctors
Matching with a residency program had an added layer of stress this year for doctors-in-training from the countries affected by President Donald Trump's travel ban.
-
Repeal & Replace Watch
Report: Fired U.S. Attorney Was Probing Tom Price’s Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
By Emily Kopp and Rachel Bluth -
Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
By Liz Szabo -
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
-
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Repeal & Replace Watch
By The Numbers: Trump’s Choice For FDA Chief Is Versatile, Entrenched In Pharma
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
-
Two Words Can Soothe Patients Who Have Been Harmed: We’re Sorry
For patients killed or maimed by medical errors, doctors and hospitals still often deny wrongdoing. But newer programs offering prompt disclosure of medical errors, an apology and compensation for them or their families are growing.
-
Repeal & Replace Watch
Say What? Fact-Checking The Chatter Around The GOP Health Bill
In the heated political arguments as Republicans rush to repeal and replace the Affordable Care Act, some facts can get buried.
By Julie Rovner -
By Law, Hospitals Now Must Tell Medicare Patients When Care Is ‘Observation’ Only
Not being officially admitted — a status known as observation care — can have financial consequences for beneficiaries, and patients had often complained they were not informed.
By Susan Jaffe